News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
51,227 Results
Type
Article (2240)
Company Profile (1)
Press Release (48986)
Section
Business (16927)
Career Advice (180)
Deals (2657)
Drug Delivery (3)
Drug Development (6829)
Employer Resources (11)
FDA (902)
Job Trends (1284)
News (27071)
Policy (2124)
Tag
Academia (332)
Allergies (5)
Alliances (3196)
ALS (3)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (12)
Approvals (893)
Artificial intelligence (18)
Automation (1)
Bankruptcy (24)
Best Places to Work (1147)
Biosimilars (2)
Biotechnology (4)
Bladder cancer (5)
Breast cancer (12)
Cancer (177)
Cardiovascular disease (9)
Career advice (152)
CAR-T (6)
Cell therapy (31)
Cervical cancer (1)
Clinical research (5554)
Collaboration (41)
Compensation (23)
Complete response letters (2)
COVID-19 (279)
CRISPR (2)
C-suite (30)
Cystic fibrosis (4)
Data (235)
Decentralized trials (1)
Diabetes (22)
Diagnostics (467)
Digital health (1)
Diversity, equity & inclusion (4)
Drug discovery (7)
Drug pricing (1)
Duchenne muscular dystrophy (4)
Earnings (5298)
Editorial (2)
Employer branding (3)
Employer resources (10)
Events (5648)
Executive appointments (112)
FDA (975)
Featured Employer (1)
Frontotemporal dementia (2)
Funding (40)
Gene editing (4)
Gene therapy (23)
GLP-1 (65)
Government (274)
Guidances (2)
Healthcare (1622)
Huntington's disease (5)
IgA nephropathy (2)
Immunology and inflammation (5)
Infectious disease (284)
Inflammatory bowel disease (11)
Influenza (2)
Intellectual property (5)
Interviews (31)
IPO (1339)
Job creations (170)
Job search strategy (138)
Layoffs (18)
Leadership (1)
Legal (534)
Liver cancer (5)
Lung cancer (28)
Lymphoma (16)
Machine learning (1)
Management (2)
Manufacturing (8)
MASH (3)
Medical device (1129)
Medtech (1130)
Mergers & acquisitions (1361)
Metabolic disorders (52)
Multiple sclerosis (11)
Neurodegenerative disease (7)
Neuropsychiatric disorders (1)
Neuroscience (163)
NextGen: Class of 2025 (559)
Non-profit (318)
Northern California (186)
Now hiring (2)
Obesity (26)
Opinion (16)
Ovarian cancer (4)
Pain (12)
Pancreatic cancer (5)
Parkinson's disease (15)
Partnered (4)
Patents (20)
Patient recruitment (13)
People (7965)
Phase I (1611)
Phase II (2664)
Phase III (1891)
Pipeline (114)
Podcasts (1)
Policy (2)
Postmarket research (143)
Preclinical (780)
Press Release (22)
Prostate cancer (12)
Psychedelics (2)
Radiopharmaceuticals (19)
Rare diseases (22)
Real estate (321)
Recruiting (3)
Regulatory (1459)
Reports (6)
Research institute (354)
Resumes & cover letters (23)
RSV (1)
Schizophrenia (4)
Series A (8)
Series B (7)
Service/supplier (1)
Sickle cell disease (3)
Southern California (183)
Special edition (2)
Spinal muscular atrophy (16)
Startups (238)
Supply chain (1)
The Weekly (1)
United States (1916)
Vaccines (37)
Venture capitalists (1)
Webinars (2)
Weight loss (6)
Women's health (1)
Date
Today (8)
Last 7 days (68)
Last 30 days (233)
Last 365 days (3074)
2025 (725)
2024 (3271)
2023 (3676)
2022 (6150)
2021 (5758)
2020 (5191)
2019 (3787)
2018 (2856)
2017 (2420)
2016 (2087)
2015 (2509)
2014 (1671)
2013 (1235)
2012 (1242)
2011 (1405)
2010 (1370)
Location
Africa (54)
Alabama (4)
Alaska (1)
Arizona (10)
Asia (2132)
Australia (379)
California (421)
Canada (213)
China (16)
Colorado (30)
Connecticut (17)
Delaware (6)
Europe (6458)
Florida (88)
Georgia (4)
Idaho (5)
Illinois (39)
Indiana (29)
Japan (3)
Kansas (3)
Kentucky (1)
Maine (13)
Maryland (77)
Massachusetts (316)
Michigan (9)
Minnesota (23)
Mississippi (1)
Missouri (8)
Nevada (2)
New Hampshire (2)
New Jersey (183)
New Mexico (1)
New York (244)
North Carolina (43)
Northern California (186)
Ohio (32)
Oklahoma (2)
Oregon (2)
Pennsylvania (143)
Puerto Rico (1)
South America (62)
South Carolina (1)
Southern California (183)
Tennessee (2)
Texas (104)
Utah (7)
Virginia (27)
Washington D.C. (6)
Washington State (63)
West Virginia (1)
Wisconsin (2)
51,227 Results for "numerate".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evaxion to present at numerous upcoming conferences
March 4, 2025
·
3 min read
Press Releases
Numerous Independent Groups Presented Data that Supports Apabetalone’s Potential Cardioprotective Benefits at European Society of Cardiology Congress 2024
Numerous GLP-1 RA and SGLT2i presentations touted their clinical results, providing continued excitement for our BETonMACE program, which observed a non-prespecified 63% reduction in MACE and heart failure hazard among patients taking next-generation glucose lowering drugs
September 3, 2024
·
6 min read
Press Releases
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
January 15, 2025
·
18 min read
Press Releases
Influenza Vaccine Market Size to Reach USD 12.5 Billion by 2032, Impelled by Numerous Favorable Initiatives by Government Bodies
July 29, 2024
·
10 min read
Inflammatory bowel disease
Equillium’s Itolizumab Goes Toe-to-Toe With Humira in Ulcerative Colitis
In a mid-stage study, the candidate itolizumab achieved 23.3% clinical remission rate at 12 weeks, numerically better than Humira’s 20% at the same time point.
February 7, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
Glaukos Corporation announced today that it will present multiple scientific abstracts at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, being held April 5-8, 2024 in Boston, MA.
April 1, 2024
·
9 min read
Press Releases
TCB Capital Advisors Expands Strategic Advisory Board
TCB strengthens its capital markets and operational advisory businesses with the addition of numerous notable Strategic Advisory Board members from across the healthcare and life sciences sectors
November 22, 2024
·
1 min read
Patent Allowance Granted for P-1 Molecule by US Patent and Trademark OfficeNovel MDMA-Like Drug Could Be Used for Numerous Neurological and Psychiatric Indications
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is thrilled to announce that allowance has been granted for the Composition of Matter of its PharmAla-1 (P-1) molecule by the US Patent and Trademark Office (USPTO).
March 20, 2024
·
4 min read
Biotech Beach
Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting
Glaukos Corporation (NYSE: GKOS) announced today that its technologies will be featured in various scientific programming at the American Academy of Ophthalmology (AAO) annual meeting, being held November 3-6, 2023 in San Francisco, CA.
October 31, 2023
·
6 min read
Bio NC
New Breath Testing Data Using Gemelli Biotech’s Trio-Smart to Be Presented at DDW 2024
Gemelli Biotech and its technologies will be featured in numerous presentations at DDW 2024.
May 16, 2024
·
3 min read
1 of 5,123
Next
